| Use this URL to cite or link to this record in EThOS: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.501643 |
|
|||||
| Title: | Humanised recombinant antibodies for human cancer therapy | ||||
| Author: | Davidson, Lisa |
ISNI:
0000 0004 2673 6788
|
|||
| Awarding Body: | The University of Strathclyde | ||||
| Current Institution: | University of Strathclyde | ||||
| Date of Award: | 2009 | ||||
| Availability of Full Text: |
|
||||
| Abstract: | |||||
|
Humanisation of rodent mAbs by CDR-grafting is now a standard procedure for reducing immunogenicity and recruiting human effector functions with ten humanised mAbs approved for use and many more in development. This project aimed to develop two anti-cancer therapeutics aimed at exploiting two tumour associated antigens overexpressed in the tumour environment.
|
|||||
| Supervisor: | Not available | Sponsor: | Not available | ||
| Qualification Name: | Thesis (Ph.D.) | Qualification Level: | Doctoral | ||
| EThOS ID: | uk.bl.ethos.501643 | DOI: | Not available | ||
| Share: | |||||